Quality & Ethics
Board of Directors
A-SKIN is open for discussion with investors or possible buyers of its IP in order to fulfil its ambition to offer advanced wound care products to fast growing patient populations.
A-SKIN develops cell and skin tissue products for the treatment of difficult to heal skin wounds.
Back to top